Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases

References

• He MM, Lo CH, Wang K, Polychronidis G, Wang L, Zhong R, Knudsen MD, Fang Z, Song M. Immune-Mediated Diseases Associated With Cancer Risks. JAMA Oncol. 2021. doi:10.1001/jamaoncol.2021.5680.
   Web of Science ®Google Scholar
• Lopez-Otin C, Kroemer G. Hallmarks of Health. Cell. 2021;184(1):33–3. doi:10.1016/j.cell.2020.11.034.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Chan TA, Kroemer G, Wolchok JD, Lopez-Soto A. The hallmarks of successful anticancer immunotherapy. Sci Transl Med . 2018;10(459):eaat7807. doi:10.1126/scitranslmed.aat7807.
   PubMed Web of Science ®Google Scholar
• Lahouel K, Younes L, Danilova L, Giardiello FM, Hruban RH, Groopman J, Kinzler KW, Vogelstein B, Geman D, Tomasetti C, et al. Revisiting the tumorigenesis timeline with a data-driven generative model. Proc Natl Acad Sci U S A. 2020;117(2):857–864. doi:10.1073/pnas.1914589117.
   PubMed Web of Science ®Google Scholar
• Ranta A, Kumar S. Recent advancements in role of TAM receptors on efferocytosis, viral infection, autoimmunity, and tissue repair. Int Rev Cell Mol Biol. 2020;357:1–19.
   PubMed Web of Science ®Google Scholar
• Marroqui L, Perez-Serna AA, Babiloni-Chust I, Dos Santos RS. Type I interferons as key players in pancreatic beta-cell dysfunction in type 1 diabetes. Int Rev Cell Mol Biol. 2021;359:1–80. doi:10.1016/bs.ircmb.2021.02.011.
   PubMed Web of Science ®Google Scholar
• Boursot P, Yonekawa H, Bonhomme F. Heteroplasmy in mice with deletion of a large coding region of mitochondrial DNA. Mol Biol Evol. 1987;4:46–55. doi:10.1093/oxfordjournals.molbev.a040421.
   PubMed Web of Science ®Google Scholar
• Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21:485–498. doi:10.1038/s41577-020-00490-y.
   PubMed Web of Science ®Google Scholar
• Aydogan BI, Mutlu ABB, Yuksel S, Gullu S, Emral R, Demir O, Sahin M, Gedik VT, Corapcioglu D, Sak SD, et al. The association of histologically proven chronic lymphocytic thyroiditis with clinicopathological features, lymph node metastasis, and recurrence rates of differentiated thyroid cancer. Endocr Pathol. 2021;32:280–287. doi:10.1007/s12022-020-09653-y.
   PubMed Web of Science ®Google Scholar
• Ryu YJ, Yoon JH. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer. Surg Oncol. 2020;34:67–73. doi:10.1016/j.suronc.2020.03.008.
   PubMed Web of Science ®Google Scholar
• Verkhovskaia S, Di Pietro FR, Mastroeni S, Carbone ML, Abeni D, Morese R, Morelli FM, D’Atri S, Marchetti P, De Galitiis F, et al. Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients. J Cancer Res Clin Oncol. 2021. doi:10.1007/s00432-021-03811-3.
   PubMed Web of Science ®Google Scholar
• Farinazzo E, Zelin E, Agozzino M, Papa G, Pizzichetta MA, Di Meo N, Zalaudek I. Regression of nevi, vitiligo-like depigmentation and halo phenomenon may indicate response to immunotherapy and targeted therapy in melanoma. Melanoma Res. 2021;31(6):582–585. doi:10.1097/CMR.0000000000000776.
   PubMed Web of Science ®Google Scholar
• Paillet J, Plantureux C, Levesque S, Le Naour J, Stoll G, Sauvat A, Caudana P, Tosello Boari J, Bloy N, Lachkar S, et al. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma. J Exp Med. 2021;218(10):e20200853. doi:10.1084/jem.20200853.
   Web of Science ®Google Scholar
• Buque A, Bloy N, Perez-Lanzon M, Iribarren K, Humeau J, Pol JG, Lévesque S, Mondragon L, Yamazaki T, Sato A, et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nat Commun. 2020;11(1):3819. doi:10.1038/s41467-020-17644-0.
   PubMed Web of Science ®Google Scholar
• Roberti MP, Yonekura S, Duong CPM, Picard M, Ferrere G, Tidjani Alou M, Rauber C, Iebba V, Lehmann CHK, Amon L, et al. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer. Nat Med. 2020;26(6):919–931. doi:10.1038/s41591-020-0882-8.
   PubMed Web of Science ®Google Scholar
• Semeraro M, Adam J, Stoll G, Louvet E, Chaba K, Poirier-Colame V, Sauvat A, Senovilla L, Vacchelli E, Bloy N, et al. The ratio of CD8 + /FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 2016;5(10):e1218106. doi:10.1080/2162402X.2016.1218106.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Perreault C, Finn OJ, Kroemer G. Beneficial autoimmunity improves cancer prognosis. Nat Rev Clin Oncol. 2021;18(9):591–602. doi:10.1038/s41571-021-00508-x.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Foulkes WD, Gordon C, Clarke AE. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis. Br J Cancer. 2011;104:1478–1481.
   PubMed Web of Science ®Google Scholar
• Clarke AE, Pooley N, Marjenberg Z, Langham J, Nicholson L, Langham S, Embleton N, Wang X, Desta B, Barut V, et al. Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51(6):1230–1241. doi:10.1016/j.semarthrit.2021.09.009.
   PubMed Web of Science ®Google Scholar
• Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther. 2015;17(1):212. doi:10.1186/s13075-015-0728-9.
   PubMed Web of Science ®Google Scholar
• Shah AA, Igusa T, Goldman D, Li J, Casciola-Rosen L, Rosen A, Petri M. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection. Arthritis Res Ther. 2021;23(1):64. doi:10.1186/s13075-021-02449-3.
   PubMed Web of Science ®Google Scholar
• Hansen JE, Chan G, Liu Y, Hegan DC, Dalal S, Dray E, Kwon Y, Xu Y, Xu X, Peterson-Roth E, et al. Targeting cancer with a lupus autoantibody. Sci Transl Med. 2012;4(157):157ra42. doi:10.1126/scitranslmed.3004385.
   Web of Science ®Google Scholar
• Gardner-Thorpe J, Ito H, Ashley SW, Whang EE. Autoantibody-mediated inhibition of pancreatic cancer cell growth in an athymic (nude) mouse model. Pancreas. 2003;27(2):180–189. doi:10.1097/00006676-200308000-00012.
   PubMed Web of Science ®Google Scholar
• Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14:717–734. doi:10.1038/nrclinonc.2017.101.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Senovilla L, Galluzzi L, Andre F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nat Med. 2015;21:1128–1138. doi:10.1038/nm.3944.
   PubMed Web of Science ®Google Scholar
• Castoldi F, Humeau J, Martins I, Lachkar S, Loew D, Dingli F, Durand S, Enot D, Bossut N, Chery A, et al. Autophagy-mediated metabolic effects of aspirin. Cell Death Discov. 2020;6(1):129. doi:10.1038/s41420-020-00365-0.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen H, Chen S, Li Z, Chen J, Li W. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. Oncoimmunology. 2021;10(1):1957605. doi:10.1080/2162402X.2021.1957605.
   PubMed Web of Science ®Google Scholar
• Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019;25(9):1428–1441. doi:10.1038/s41591-019-0566-4.
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y. Environment and lupus-related diseases. Lupus. 2012;21(3):241–250. doi:10.1177/0961203311426568.
   PubMed Web of Science ®Google Scholar
• Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017;31(3):373–396. doi:10.1016/j.berh.2017.09.013.
   PubMed Web of Science ®Google Scholar